Publicacións en colaboración con investigadores/as de Ikerbasque, Fundación Vasca para la Ciencia (27)

2024

  1. Neddylation orchestrates the complex transcriptional and posttranscriptional program that drives Schwann cell myelination

    Science Advances, Vol. 10, Núm. 15

2023

  1. Enhanced mitochondrial activity reshapes a gut microbiota profile that delays NASH progression

    Hepatology, Vol. 77, Núm. 5, pp. 1654-1669

  2. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

2022

  1. Application of adipose-derived mesenchymal stem cells in an in vivo model of peripheral nerve damage

    Frontiers in Cellular Neuroscience, Vol. 16

  2. HuR-targeted agents: An insight into medicinal chemistry, biophysical, computational studies and pharmacological effects on cancer models

    Advanced Drug Delivery Reviews, Vol. 181

  3. Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis

    Nature Communications, Vol. 13, Núm. 1

  4. Mitochondrial bioenergetics boost macrophage activation, promoting liver regeneration in metabolically compromised animals

    Hepatology, Vol. 75, Núm. 3, pp. 550-566

2021

  1. Axo-glial interaction in the injured PNS

    Developmental Neurobiology, Vol. 81, Núm. 5, pp. 490-506

  2. Boosting mitochondria activity by silencing MCJ overcomes cholestasis-induced liver injury

    JHEP Reports, Vol. 3, Núm. 3

  3. E2F1 and E2F2-mediated repression of CPT2 establishes a lipid-rich tumor-promoting environment

    Cancer Research, Vol. 81, Núm. 11, pp. 2874-2887

  4. O-GlcNAcylated p53 in the liver modulates hepatic glucose production

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Silencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation

    Nature Communications, Vol. 11, Núm. 1

  2. Targeting Hepatic Glutaminase 1 Ameliorates Non-alcoholic Steatohepatitis by Restoring Very-Low-Density Lipoprotein Triglyceride Assembly

    Cell Metabolism, Vol. 31, Núm. 3, pp. 605-622.e10

2019

  1. miR-873-5p targets mitochondrial GNMT-Complex II interface contributing to non-alcoholic fatty liver disease

    Molecular Metabolism, Vol. 29, pp. 40-54

2018

  1. Analyzing autophagic flux in nerve cultures

    Methods in Molecular Biology (Humana Press Inc.), pp. 193-206

  2. Isolation and purification of primary rodent schwann cells

    Methods in Molecular Biology (Humana Press Inc.), pp. 81-93

  3. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis

    Cell Death and Disease, Vol. 9, Núm. 10

  4. Preface

    Methods in Molecular Biology

2017

  1. Role of aramchol in steatohepatitis and fibrosis in mice

    Hepatology Communications, Vol. 1, Núm. 9, pp. 911-927

  2. The mitochondrial negative regulator MCJ is a therapeutic target for acetaminophen-induced liver injury

    Nature Communications, Vol. 8, Núm. 1